Control Bionics Limited (ASX:CBL)
Australia · Delayed Price · Currency is AUD 0.0410
+0.0030 (7.89%)
Nov 5, 2025, 3:22 PM AEST
Control Bionics Market Cap
Control Bionics has a market cap or net worth of 13.79 million as of November 5, 2025. Its market cap has increased by 28.14% in one year.
Market Cap
13.79M
Enterprise Value
13.55M
Revenue
6.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since December 7, 2020, Control Bionics's market cap has decreased from 98.33M to 13.79M, a decrease of -85.98%. That is a compound annual growth rate of -32.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 13.79M | -8.79% |
| Dec 31, 2024 | 15.12M | 126.88% |
| Dec 29, 2023 | 6.66M | -55.36% |
| Dec 30, 2022 | 14.93M | -59.58% |
| Dec 30, 2021 | 36.94M | -52.85% |
| Dec 31, 2020 | 78.33M | -20.34% |
| Dec 7, 2020 | 98.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 85.54B |
| Pro Medicus | 27.34B |
| Cochlear | 18.36B |
| Sonic Healthcare | 10.27B |
| Ramsay Health Care | 7.27B |
| Telix Pharmaceuticals | 5.35B |
| Ansell | 5.20B |
| Mesoblast | 3.18B |